Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
100
NCT05846971
Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus
Phase: N/A
Role: Lead Sponsor
Start: Jan 26, 2021
Completion: Dec 31, 2023